Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways
Benjamin Stump(Brigham and Women's Hospital), Souheil El‐Chemaly(AVEO Oncology (United States)), Iván O. Rosas(Brigham and Women's Hospital), Shikshya Shrestha(Brigham and Women's Hospital), Woohyun Cho(Brigham and Women's Hospital), Xingbin Ai(Massachusetts General Hospital), Florence F. Wagner(Broad Institute), Mark A. Perrella(Brigham and Women's Hospital), Jonathan W. Astin(University of Auckland), Anthony M. Lamattina(Harvard University), Carmen Priolo(Brigham and Women's Hospital), Pierce H. Louis(Brigham and Women's Hospital)
Cited by 14
Related Papers
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
|New England Journal of Medicine|2011|615
MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
|PLoS Medicine|2008|599